JP2023532272A5 - - Google Patents
Info
- Publication number
- JP2023532272A5 JP2023532272A5 JP2022579923A JP2022579923A JP2023532272A5 JP 2023532272 A5 JP2023532272 A5 JP 2023532272A5 JP 2022579923 A JP2022579923 A JP 2022579923A JP 2022579923 A JP2022579923 A JP 2022579923A JP 2023532272 A5 JP2023532272 A5 JP 2023532272A5
- Authority
- JP
- Japan
- Prior art keywords
- syndrome
- composition according
- cytokine
- virus
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063043636P | 2020-06-24 | 2020-06-24 | |
| US63/043,636 | 2020-06-24 | ||
| PCT/US2021/038512 WO2021262735A2 (en) | 2020-06-24 | 2021-06-22 | Antagonistic peptide targeting il-2, il-9, and il-15 signaling for the treatment of cytokine-release syndrome and cytokine storm associated disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023532272A JP2023532272A (ja) | 2023-07-27 |
| JP2023532272A5 true JP2023532272A5 (enExample) | 2024-07-19 |
Family
ID=79282811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579923A Pending JP2023532272A (ja) | 2020-06-24 | 2021-06-22 | サイトカイン放出症候群およびサイトカインストーム関連障害の治療用の、ｉｌ－２、ｉｌ－９およびｉｌ－１５のシグナル伝達を標的とするアンタゴニストペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230338473A1 (enExample) |
| EP (1) | EP4172175A4 (enExample) |
| JP (1) | JP2023532272A (enExample) |
| KR (1) | KR20260042328A (enExample) |
| CN (1) | CN116615221A (enExample) |
| AU (1) | AU2021297801A1 (enExample) |
| CA (1) | CA3186973A1 (enExample) |
| WO (1) | WO2021262735A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12600757B2 (en) | 2017-04-07 | 2026-04-14 | Bioniz Therapeutics, Inc. | Peptides inhibiting gamma-c-cytokine activity and methods of use |
| CA3137971A1 (en) | 2019-05-03 | 2020-11-12 | Bioniz, Llc | Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia associated disorders |
| CN114188014A (zh) * | 2021-09-28 | 2022-03-15 | 中国医学科学院阜外医院 | 一种患者院内不良预后预测模型构建方法、系统及应用 |
| CN116355844B (zh) * | 2023-05-31 | 2023-08-18 | 吉林大学第一医院 | 一种SARS-CoV-2抗原诱发细胞因子风暴模型的建立及应用 |
| WO2026008069A1 (zh) * | 2024-07-05 | 2026-01-08 | 深圳市济因生物科技有限公司 | 细胞因子拮抗剂在制备预防和/或治疗crs的药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2840089A1 (en) * | 2002-01-18 | 2015-02-25 | ZymoGenetics, Inc. | Cytokine receptor zcytor17 multimers |
| EP2665486B1 (en) * | 2011-01-18 | 2019-12-25 | Bioniz, LLC | Compositions for modulating gamma-c-cytokine activity |
| US9959384B2 (en) * | 2013-12-10 | 2018-05-01 | Bioniz, Llc | Methods of developing selective peptide antagonists |
| WO2017062685A1 (en) * | 2015-10-09 | 2017-04-13 | Bioniz, Llc | Modulating gamma - c -cytokine activity |
| US12600757B2 (en) * | 2017-04-07 | 2026-04-14 | Bioniz Therapeutics, Inc. | Peptides inhibiting gamma-c-cytokine activity and methods of use |
| CA3137971A1 (en) * | 2019-05-03 | 2020-11-12 | Bioniz, Llc | Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia associated disorders |
-
2021
- 2021-06-22 EP EP21829639.0A patent/EP4172175A4/en not_active Withdrawn
- 2021-06-22 CA CA3186973A patent/CA3186973A1/en active Pending
- 2021-06-22 JP JP2022579923A patent/JP2023532272A/ja active Pending
- 2021-06-22 KR KR1020237002344A patent/KR20260042328A/ko active Pending
- 2021-06-22 CN CN202180058511.7A patent/CN116615221A/zh active Pending
- 2021-06-22 WO PCT/US2021/038512 patent/WO2021262735A2/en not_active Ceased
- 2021-06-22 US US18/002,732 patent/US20230338473A1/en active Pending
- 2021-06-22 AU AU2021297801A patent/AU2021297801A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023532272A5 (enExample) | ||
| ES2334773T3 (es) | Uso de inhibidores de il-18 para el tratamiento o prevencion de la sepsis. | |
| JP7250790B2 (ja) | Ｉｌ－２ムテインおよびその使用 | |
| JP2016527314A5 (enExample) | ||
| JP2019510739A5 (enExample) | ||
| JP2022521591A5 (enExample) | ||
| JP2015502340A5 (enExample) | ||
| JP2005512507A5 (enExample) | ||
| JP2008523083A5 (enExample) | ||
| Heck et al. | Pharmacological therapy of bronchial asthma: the role of biologicals | |
| RU2016151265A (ru) | Антитела, направленные на cd127 | |
| JP2023514128A5 (enExample) | ||
| JP2008501716A5 (enExample) | ||
| JP2006524986A5 (enExample) | ||
| CA2920293A1 (en) | Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant | |
| JP2017113019A5 (enExample) | ||
| US10456456B2 (en) | Anti-IL-6 vaccine composition | |
| RU2007126553A (ru) | Упорядоченные ряды антигенов ил-15 и их применение | |
| RU2014120694A (ru) | ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К iNKT | |
| JP2018505893A5 (enExample) | ||
| SK12082002A3 (sk) | Použitie IL-18 inhibítorov a farmaceutický prostriedok s obsahom IL-18 inhibítorov | |
| RU2014106933A (ru) | Способы и композиции для лечения аутоиммунных и воспалительных заболеваний | |
| Stirling et al. | Future treatments of allergic diseases and asthma | |
| US20230338473A1 (en) | Antagonistic peptide targeting il-2, il-9, and il-15 signaling for the treatment of cytokinerelease syndrome and cytokine storm associated disorders | |
| JP2021504382A5 (enExample) |